AstraZeneca: executive compensation 2025
AstraZeneca paid Pascal Soriot £17.7m for 2025: £1.86m fixed, a £4.26m bonus (92% of the maximum) and £11.6m from LTIP awards.
Pascal Soriot, CEO
Aradhana Sarin, CFO
Pay by element
| GBP | Pascal Soriot | Aradhana Sarin |
|---|---|---|
| Salary | £1.54m | £990k |
| Benefits | £143k | £10k |
| Pension | £170k | £109k |
| Total fixed | £1.86m | £1.11m |
| Annual bonus | £4.26m | £1.60m |
| LTIP vesting | £11.6m | £5.13m |
| Total | £17.7m | £7.85m |
| Previous year | £16.6m | £7.59m |
Bonus scorecard: Annual bonus (Group scorecard)
Pascal Soriot: maximum 300% of salary, paid 92% of the maximum. Aradhana Sarin: maximum 200% of salary, paid 81% of the maximum. Scorecard result: 147% of target.
| Measure | Weighting | Threshold | Target | Maximum | Result | Paid, points of the total |
|---|---|---|---|---|---|---|
| Science and innovation: pipeline progression events | 15% | 15 | 29 | 44 | 36 | 22 |
| Science and innovation: regulatory events | 15% | 38 | 54 | 70 | 69 | 29 |
| Growth and therapy area leadership: total revenue ($bn) | 30% | 56.5 | 58.2 | 60.0 | 59.0 | 43 |
| Group financial targets: cash flow ($bn) | 20% | 9.6 | 11.3 | 13.0 | 11.9 | 27 |
| Group financial targets: core EPS ($) | 20% | 8.65 | 9.10 | 9.56 | 9.24 | 26 |
Deferral: Half of pre-tax bonus compulsorily deferred into shares released after three years.
LTIP: Performance Share Plan (2023 award)
Vested at 97% of the maximum. Pascal Soriot's award was 850% of salary. Aradhana Sarin's award was 550% of salary.
| Measure | Weighting | Result |
|---|---|---|
| Science and innovation: first approvals and new medicine volume over three years | 30% | 30% |
| Growth and therapy area leadership | 20% | 20% |
| Cash flow | 20% | 20% |
| Total shareholder return | 20% | 17% |
| Ambition Zero Carbon | 10% | 10% |
CEO pay ratio
261:1 against the lower-quartile UK employee, 176:1 against the median, 118:1 against the upper quartile.
Notes
Each bonus measure's result is its contribution as a percentage of target bonus; the scorecard paid 147% of target. LTIP values are estimated at a three-month average share price.
Source: AstraZeneca's annual report for 2025 (pay table page 97, bonus scorecard page 99, LTIP awards page 103, pay ratio page 110).
CEO pay at every companyRead from the company's own annual report and checked by arithmetic: pay adds up for Pascal Soriot; pay adds up for Aradhana Sarin; scorecard weightings add to 100%; measure payouts add up to the stated outcome; salary x maximum x outcome gives Pascal Soriot's bonus; salary x maximum x outcome gives Aradhana Sarin's bonus. Figures are as the company reported them, in its own currency. How it works.